Lei Zhang, MD
Institute of Hematology & Blood Diseases Hospital, China
10
10
1
N/A
0
4
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+3 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (10)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Rongfeng Fu
Institute of Hematology & Blood Diseases Hospital, China
Shared therapeutic areas:
Worked with same sponsors:
Rong Fu
Tianjin Medical University General Hospital
Shared therapeutic areas:
Worked with same sponsors:
lei zhang, MD
Chinese Academy of Medical Science and Blood Disease Hospital
Shared therapeutic areas:
Worked with same sponsors:
Program Director
CSL Behring
Shared therapeutic areas:
Ellis Neufeld, MD
Boston Children's Hospital
Shared therapeutic areas:
Thomas Ortel, MD
Duke University
Shared therapeutic areas:
Lung-Ji Chang, PhD
Shenzhen Geno-Immune Medical Institute
Shared therapeutic areas:
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Shared therapeutic areas:
Nigel Key, MD
University of North Carolina, Chapel Hill
Shared therapeutic areas:
Charles Conway, MD
Washington University School of Medicine
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (10)
Showing 10 of 10 trials
Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia
Safety and Efficacy Study of NGGT003 in Hemophilia A Patients
Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV
The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.
The Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients.
Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia
A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients
TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia
All 10 trials loaded